Ads
related to: Accounts Receivable Factoring
Search results
Timken Prices €600 Million Senior Notes Due in 2034
WJTV Jackson· 6 days agoThe Notes will be issued at 98.832% of par, and the offering is expected to close on or about May 23, 2024, subject to the satisfaction of customary closing conditions. Goldman Sachs & Co. LLC ...
Exagen Inc (XGN) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Margin ...
GuruFocus.com via Yahoo Finance· 7 days agoExagen Inc (XGN) reports a robust financial performance with significant improvements in revenue, gross margin, and adjusted EBITDA in the first quarter of 2024.
Mace(R) Security International, a Global Leader in Personal Self-Defense Sprays, Announces 1Q24...
Morningstar· 6 days agoCLEVELAND, OH / ACCESSWIRE / May 15, 2024 / Mace Security International (OTCQB:MACE) today announced its first quarter 2024 financial results for the period ended March 31, 2024. The Company's ...
Reliance Global Group Inc (RELI) Q1 2024 Earnings Call Transcrip
Guru Focus· 2 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. The acquisition of Spectrum is anticipated to more than double the company's revenue, bringing in over $14 million in revenue for fiscal year 2024.
AnalytixInsight Provides MCTO Status Update
Benzinga· 4 days agoAnalytixInsight Inc. ("AnalytixInsight", or the "Company") ALY today provides a default status report in accordance with the alternative information guidelines set out in National Policy 12- ...
Earnings call: Bridgeline Digital sees dip in Q2 revenue, bullish on HawkSearch growth By...
Investing.com· 3 days agoBridgeline Digital (ticker: BLIN), a provider of AI-powered site search technologies, reported a...
Earnings call: IRIDEX reports Q1 2024 revenue decline, ongoing strategic review By Investing.com
Investing.com· 3 days agoIRIDEX Corporation (IRIX), a medical technology company specializing in ophthalmic laser therapies,...
Earnings call: IRIDEX reports Q1 2024 revenue decline, ongoing strategic review
Investing.com· 4 days agoIRIDEX Corporation (IRIX), a medical technology company specializing in ophthalmic laser therapies,...
Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and...
Digital Journal· 7 days ago...Cash $ 3,786,184 $ 2,274,259 Prepaid expenses and other current assets 1,058,836 1,677,396 Incentive tax receivable 377,962 786,574 Total current assets 5,222,982 4,738,229 Property and equipment, net 26,944 33,366 Operating...206 Total assets $ 5,909,409 $ 5,429,478 Liabilities and stockholders'...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoBOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson
